It has been said that what starts here can change the world because Prevacus has developed the first drug for the treatment of concussions. AloeMD, a product of AloeVeritas, mirrors and accelerates some of Prevacus’ ingredients, is an enhanced delivery system for the drug.Dr. Jake VanLandingham, founder and CEO of Prevacus, and Christopher Hardy, founder and CEO of AloeVeritas, discuss this with Late Night Health’s Mark Alyn.